Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.
Morning Overview on MSN
A common blood-pressure drug may be quietly speeding kidney damage in people with diabetes
Millions of people with type 2 diabetes take a blood-pressure pill every day on the understanding that lowering their numbers ...
Diabetic nephropathy is a common complication associated with diabetes that affects a person’s kidneys. Several medications may help slow the progression of kidney damage. Early treatment can prevent ...
Morning Overview on MSN
A kidney drug slowed disease in patients who don’t even have diabetes
Chronic kidney disease has long been treated most aggressively when it stems from diabetes, the condition behind a large ...
After the diagnosis of micro- or macroalbuminuria is confirmed, patients should undergo a complete evaluation, including a work-up for other etiologies and an assessment of renal function and the ...
Diabetic kidney disease (DKD) represents a leading cause of chronic kidney failure worldwide, arising from hyperglycaemia-induced damage to glomerular and tubular structures. Early stages are often ...
Patients with T1D face a higher risk for any fractures, major osteoporotic fractures, and hip fractures than control ...
Diabetic nephropathy is a leading cause of chronic kidney disease and end-stage renal failure in people with type 1 and type 2 diabetes. Rodent systems—including mice and rats—have been instrumental ...
Please provide your email address to receive an email when new articles are posted on . Of patients with diabetes undergoing kidney biopsy, 37.2% had diabetic kidney disease alone. Researchers found ...
Please provide your email address to receive an email when new articles are posted on . Three biomarkers in urine may be used to noninvasively assess tubule and interstitial health in diabetic kidney ...
As glucagon-like peptide-1 (GLP-1) receptor agonists become increasingly popular medications used to treat both type 2 diabetes and obesity, the question is raised: How do GLP-1s impact kidney health?
The alarming scale of India's metabolic crisis has reached a critical juncture in the National Capital Region (NCR). According to a landmark study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results